Log in

NASDAQ:EKSOEkso Bionics Stock Price, Forecast & News

$7.35
+0.12 (+1.66 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$7.16
Now: $7.35
$7.94
50-Day Range
$3.00
MA: $4.43
$8.77
52-Week Range
$2.25
Now: $7.35
$19.65
Volume1.09 million shs
Average Volume8.97 million shs
Market Capitalization$55.79 million
P/E RatioN/A
Dividend YieldN/A
Beta2.06
Ekso Bionics Holdings, Inc. designs, develops, and sells exoskeletons for use in the healthcare, industrial, and military markets in North America, Europe, the Middle East, and Africa. The company operates through EksoHealth and EksoWorks segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries and hemiplegia due to stroke. The company's Ekso device is primarily used in a hospital and rehabilitation setting. The company has a license agreement with Lockheed Martin Corporation, Regents of the University of California, and Garrett Brown, as well as with OttoBock Healthcare Products Gmbh. The company was founded in 2005 and is headquartered in Richmond, California.
Read More
Ekso Bionics logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.37 out of 5 stars


Industry, Sector and Symbol

Industry General industrial machinery,
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:EKSO
Previous SymbolOTCMKTS:EKSOD
CUSIPN/A
Phone510-984-1761

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$13.92 million
Book Value$1.17 per share

Profitability

Net Income$-12,130,000.00

Miscellaneous

Employees77
Market Cap$55.79 million
Next Earnings Date8/6/2020 (Estimated)
OptionableNot Optionable

Receive EKSO News and Ratings via Email

Sign-up to receive the latest news and ratings for EKSO and its competitors with MarketBeat's FREE daily newsletter.

Ekso Bionics (NASDAQ:EKSO) Frequently Asked Questions

How has Ekso Bionics' stock been impacted by COVID-19 (Coronavirus)?

Ekso Bionics' stock was trading at $0.2616 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, EKSO shares have increased by 2,709.6% and is now trading at $7.35. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Ekso Bionics?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ekso Bionics in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Ekso Bionics.

When is Ekso Bionics' next earnings date?

Ekso Bionics is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Ekso Bionics.

How were Ekso Bionics' earnings last quarter?

Ekso Bionics Holdings Inc (NASDAQ:EKSO) issued its earnings results on Thursday, April, 30th. The company reported ($0.44) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.61) by $0.17. The business earned $1.47 million during the quarter. Ekso Bionics had a negative net margin of 68.97% and a negative return on equity of 210.43%. View Ekso Bionics' earnings history.

When did Ekso Bionics' stock split? How did Ekso Bionics' stock split work?

Shares of Ekso Bionics reverse split on Thursday, May 5th 2016. The 1-7 reverse split was announced on Wednesday, May 4th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, May 4th 2016. An investor that had 100 shares of Ekso Bionics stock prior to the reverse split would have 14 shares after the split.

What guidance has Ekso Bionics issued on next quarter's earnings?

Ekso Bionics updated its first quarter 2020 After-Hours earnings guidance on Thursday, April, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.4-1.5 million, compared to the consensus revenue estimate of $3.63 million.

What price target have analysts set for EKSO?

3 equities research analysts have issued 1-year target prices for Ekso Bionics' stock. Their forecasts range from $8.00 to $13.00. On average, they anticipate Ekso Bionics' share price to reach $11.00 in the next year. This suggests a possible upside of 49.7% from the stock's current price. View analysts' price targets for Ekso Bionics.

What are Wall Street analysts saying about Ekso Bionics stock?

Here are some recent quotes from research analysts about Ekso Bionics stock:
  • 1. According to Zacks Investment Research, "Ekso Bionics Holdings, Inc. is engaged in designing, developing and selling wearable robots or exoskeletons for the medical, military, industrial and consumer markets. The company's operating segment consists of Engineering Services and Medical segments. It operates primarily in North America, Western Europe, the Middle East and South Africa. Ekso Bionics Holdings, Inc. is headquartered in Richmond, California. " (6/18/2020)
  • 2. Aegis analysts commented, "We think conversion rate is an interesting metric to follow as it is representative of accounts which trialed the Ekso GT via the rental program, and then decided to make the capital commitment, which is significant, at around $130K per Ekso GT." (8/8/2019)

Has Ekso Bionics been receiving favorable news coverage?

News coverage about EKSO stock has been trending negative this week, InfoTrie reports. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Ekso Bionics earned a daily sentiment score of -2.2 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 5.0 out of 10, indicating that recent media coverage is somewhat likely to have an impact on the stock's share price in the immediate future. View the latest news about Ekso Bionics.

Who are some of Ekso Bionics' key competitors?

What other stocks do shareholders of Ekso Bionics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ekso Bionics investors own include TransEnterix (TRXC), Amplify Energy (AMPY), Amplify Energy (AMPY), Chesapeake Energy (CHK), XOMA (XOMA), OrganiGram (OGI), Zosano Pharma (ZSAN), Infinity Augmented Reality (ALSO), KushCo (KSHB) and Miragen Therapeutics (MGEN).

Who are Ekso Bionics' key executives?

Ekso Bionics' management team includes the following people:
  • Mr. Steven A. Sherman, Exec. Chairman (Age 73)
  • Mr. Jack Peurach, Pres, CEO & Director (Age 53)
  • Mr. John F. Glenn, CFO & Sec. (Age 57)
  • Mr. William Shaw, Chief Commercial Officer (Age 45)
  • Ms. Foon Lim Chwee, Pres of APAC

What is Ekso Bionics' stock symbol?

Ekso Bionics trades on the NASDAQ under the ticker symbol "EKSO."

How do I buy shares of Ekso Bionics?

Shares of EKSO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Ekso Bionics' stock price today?

One share of EKSO stock can currently be purchased for approximately $7.35.

How big of a company is Ekso Bionics?

Ekso Bionics has a market capitalization of $55.79 million and generates $13.92 million in revenue each year. The company earns $-12,130,000.00 in net income (profit) each year or ($3.45) on an earnings per share basis. Ekso Bionics employs 77 workers across the globe.

What is Ekso Bionics' official website?

The official website for Ekso Bionics is www.eksobionics.com.

How can I contact Ekso Bionics?

Ekso Bionics' mailing address is 1414 HARBOUR WAY SOUTH SUITE 1201, RICHMOND CA, 94804. The company can be reached via phone at 510-984-1761 or via email at [email protected]

This page was last updated on 7/5/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.